Chemical Technology, Raw Materials
prnewswire | August 04, 2023
Enerkem Inc. and Technip Energies have signed a memorandum of understanding to enter into a Collaboration Agreement aimed at accelerating the deployment of Enerkem's technology platform for biofuels and circular chemical products from non-recyclable waste materials.
Enerkem specializes in the development and commercialization of its groundbreaking gasification technology transforming non-recyclable waste into biofuels, low-carbon fuels and circular chemicals, catering to hard-to-abate sectors such as sustainable aviation and marine fuels. Since 2016, Enerkem has been operating a commercial demonstration scale facility in Alberta, Canada. Additionally, the company is currently involved in the development and construction of new commercial-scale waste-to-methanol facilities in Canada and Europe.
Technip Energies, having successfully executed bio and low-carbon fuels projects worldwide, will contribute its expertise in engineering, technology integration and project delivery to support projects developed by Enerkem. This partnership will enhance Enerkem's project delivery capacity and speed. Furthermore, the collaboration will focus on strategic efforts to optimize design elements and industrialize the approach through the replication of Enerkem's designs for future projects.
To expedite the deployment of its technology, Enerkem intends to establish a Development Company (DevCo). The purpose of DevCo is to acquire sites and secure relevant permits for the replicable methanol biorefinery design, supporting the production of bio and low-carbon fuels, as well as circular chemicals.
Dominique Boies, CEO of Enerkem, stated: "We are excited to partner with Technip Energies to accelerate the deployment of Enerkem's technology in Europe, North America, and the Middle East. Technip Energies' extensive expertise will enable Enerkem's clients to benefit from projects speed to market and cost efficiencies, supporting their decarbonization efforts and sustainability goals."
Bhaskar Patel, SVP Sustainable Fuels, Chemicals and Circularity of Technip Energies, said: "We are pleased to join forces with Enerkem on the deployment of its technology platform to convert waste into sustainable and valuable end products such as biofuels. By leveraging our expertise in engineering, sustainable chemistry and biofuels projects, we will support project execution and Enerkem's technology deployment."
About Enerkem
Founded in 2000, Enerkem develops and commercializes its groundbreaking gasification technology transforming non-recyclable waste into biofuels, low-carbon fuels and circular chemicals for hard-to-abate sectors, including sustainable aviation and marine fuels. Its solution tackles both challenges of waste management and dependency on fossil fuel products while contributing to the development of a circular economy for a sustainable, net-zero-carbon future.
Headquartered in Montreal, Enerkem employs close to 300 people in Canada, the United States, Europe and the UK, and has various projects worldwide, including the world's first commercial scale biorefinery producing advanced bio-methanol and circular methanol from non-recyclable waste in Alberta, Canada. In partnership with key strategic partners, a large-scale facility based on Enerkem's waste-to-methanol platform is under construction in Quebec, Canada, and is scheduled to start operations in 2025. In Tarragona, Spain, Enerkem's technology is at the heart of the Ecoplanta project which will produce biomethanol and circular methanol from non-recyclable waste.
About Technip Energies
Technip Energies is a leading Engineering & Technology company for the energy transition, with leadership positions in Liquefied Natural Gas (LNG), hydrogen and ethylene as well as growing market positions in blue and green hydrogen, sustainable chemistry, and CO2 management.
Read More
Chemical Management
prnewswire | September 12, 2023
Lummus Technology, a global provider of process technologies and value-driven energy solutions, and RWDC Industries, a biotechnology company developing biopolymer material solutions, announced a binding Joint Development and Commercial Cooperation Agreement (JDCCA) to rapidly expand manufacturing and global licensing of polyhydroxyalkanoates (PHA). In April, Lummus and RWDC signed a memorandum of understanding (MOU) to cooperate on global PHA deployment initiatives.
"This agreement highlights Lummus and RWDC's strong commitment to addressing plastic waste and the carbon footprint associated with conventional plastics production," said Leon de Bruyn, Lummus Technology's President and Chief Executive Officer. "Our partnership in this innovative space aligns with the United Nations' Sustainable Development Goals, reflecting our ongoing dedication to developing technologies that accelerate the use and availability of eco-friendly plastics."
"We look forward to the value that will be created in combining Lummus' expertise with ours to improve people's lives and health by making PHA polymers and resins available at large scale," said Dr. Daniel Carraway, RWDC's Chief Executive Officer. "It has always been our goal to develop sustainable materials that benefit every living thing on the planet, and this partnership is a monumental step in that direction. Lummus' and RWDC's decision to work together is an exciting development toward making it possible for more people to benefit from natural materials while preserving resources and our environment for future generations."
RWDC uses plant-based oils, including post-consumer or waste cooking oils, to produce its proprietary Solon™ PHA, which can be organically recycled or composted in home and industrial composting facilities. Products or packaging made with PHA that find their way into the environment, therefore, will fully biodegrade in soil, fresh water, and marine settings, preventing persistent plastics and microplastics from accumulating in the environment. Articles produced with PHA also can be recycled, re-used or returned to the carbon cycle by way of organic recycling or composting systems.
Lummus' interest in pursuing this partnership is testament to RWDC's attractiveness to licensors, due to its demonstrable technology innovation and technical capabilities; commercial value proposition and unit economics; and existing global brand partnerships that continuously validate market demand.
RWDC is uniquely positioned as the only PHA manufacturer in the market to provide scalable and cost-effective biopolymer production and first- and best-in-class formulation capabilities and guidance on conversion for product development. Licensing and technology development through its forthcoming partnership with Lummus further enhances RWDC's position as a market leader. Moreover, Lummus' polymer expertise, illustrated through its Novolen® polypropylene technology, highlights a commitment to innovation and sustainable solutions in polyolefin technology to drive transformative change within the plastics industry.
About Lummus
Lummus Technology is the global leader in developing technology solutions that make modern life possible and focus on a more sustainable, low carbon future. We license process technologies in clean fuels, renewables, petrochemicals, polymers, gas processing and supply lifecycle services, catalysts, proprietary equipment and digitalization to customers worldwide.
About RWDC Industries
Founded in 2016, RWDC Industries is a biotechnology company that utilizes natural processes to produce materials for use in our daily lives. RWDC develops innovative, cost-effective biopolymer material solutions, including Solon™ PHA, a fully biodegradable and environmentally safe material that can replace plastic in a wide range of applications from single use articles to consumer goods or food packaging to non-wovens and textiles. RWDC supports sustainable practices and encourages responsible choice in plastic waste management, including recycling, to protect our environment and planet. Its global headquarters is in Singapore and operational headquarters is in Athens, Georgia.
Read More
Chemical Management
businesswire | September 26, 2023
Actylis, a leading global manufacturer of critical raw materials and performance ingredients for the life sciences and specialty chemicals markets, today announced the launch of Water for Injection (WFI) and additional ISO Class 7 manufacturing space at its Baie d’Urfé site in Montreal, Canada. Used for the preparation of media, buffers, and other aqueous solutions, Actylis’ WFI meets monographs for pharmacopoeias worldwide, and can be provided in both custom and standard packaging configurations.
Gilles Cottier, CEO at Actylis, said: “Today we are delighted to announce the opening of this new WFI system at our Baie d’Urfé site. Investment in this new WFI generation, storage, and distribution system reflects our ongoing commitment to support our customers, and to continuously develop our range of products and services. The new system positions us to be a preferred outsource partner for our customers’ buffer solutions. We understand that capacity is often a pinch-point for our customers, and we are delighted to be able to propose this option to them.”
Damien O’Rourke, SVP Manufacturing Operations at Actylis added: “Our new WFI system, redundant with our Limerick, Ireland WFI capabilities, incorporates the latest advancements in water purification technology, adhering to Good Manufacturing Practices (cGMP) that guarantees the production of WFI that meets or exceeds the most rigorous quality standards. In addition to the services this enables for our customers, the investment provides Actylis and our customers with a robust multi-site business continuity plan to ensure dependable supply.”
Jean-Francois Raymond, Site Director, elaborated on some of the specifics of the system: “We are excited to have this new system here at Baie d’Urfé come on stream. The WFI system is fully qualified with all supporting validation documents, and is capable of generating and maintaining water as per required USP and PhEur/BP specifications of Water for Injection.”
The new system’s strategic location in Montreal positions it as a pivotal hub for biopharmaceutical companies across North America and beyond. Its proximity to major transportation networks ensures timely distribution of WFI to manufacturers, enabling them to streamline their production processes and meet growing market demands.
About Actylis
Actylis is a leading global manufacturer and supplier of differentiated specialty ingredients to life sciences and specialty chemicals end markets. With business operations in ten countries, Actylis manufactures and supplies over 4,500 chemical compounds used principally by the pharmaceutical, biopharmaceutical, nutritional, agricultural and specialty chemical industries. Building on a series of strategic acquisitions, Actylis has integrated their manufacturing, R&D, quality, and sourcing capabilities to create a worldwide supplier of critical raw materials that includes a robust manufacturing footprint. Its global operations include a significant presence on the ground in North America, Europe, India, and China. Actylis is well positioned to innovate new solutions, ensure quality, and customize products to meet customers’ specific needs. Its expanded capabilities and decades of global sourcing expertise are especially valuable now that supply chain management is a critical strategic issue for companies worldwide.
Read More